Hemant Kumar Vyas Phd Email & Phone Number

Amsterdam, 1105Bp, Nl

Dublin, Ie

Led Sci Comm project development (oncology), generation of medical and publication plans, and implementation and maintenance of these plans.Provided expertise in publication strategies. Participated in long-range planning and led multifunctional publication planning team meetings for clinical and pre-clinical programs.Managed the development and approval of the scientific congress booth-based reactive and proactive information decks.Coordinated activities with Field MSL teams.Ensured consistency with GPP3 Good Publication Practices, ICMJE guidelines, and company SOPs. Identified appropriate target journals and congresses for submission of publications and ensured deadlines were met.

Waltham, Massachusetts, Us

Developed, implemented, and maintained publication plans. Datavision expert. Managed cross-functional teams to plan and develop medical and scientific publications, and ensured archiving and complaint access of Medical Communication materials.Managed external and internal medical writers with three writing agencies; coordinated multiple concurrent projects.Partnered with statisticians, medical directors, and external experts to strategically develop post hoc analyses of clinical data for publication. Fostered the establishment and maintenance of communication with key thought leaders in research and early development through gaining knowledge on their insights and development of scientific publications. Maintained publication workflow on the database (Datavision). Lead providing access and publication metrics to the company leadership.

San Antonio, Texas, Us

Research Area:Targeted therapy and vaccine development. Assay development for detection of viral contaminants using primer design and PCR.Epitope-specific monoclonal antibody engineering and functional characterization.Passive immunization studies in primate models. RT-PCR for studying viral copies and quantitative cell assays. Development of standards, primer, and probe designing for HIV-1 Gag qPCR.Antibody genome analysis and antibody sequence database generation.Investigated humoral correlates of protection in primate vaccine studies. Provided technical support and troubleshooting with experiments, instrumentation, and database management.Coordinated and conducted preclinical and primate studies.Served as writing expert on grant proposals of novel research projects sponsored by NIH, Melinda and Bill Gates foundation, Henry M Jackson Foundation, and the Department of Defense in immunology and virology programs.Supervised 3-5 post-grads and Master’s students per year for their projects, dissertations, and internships. Co-supervised two Ph.D. students for their BSL3 lab projects.Completed several key pre-clinical manuscripts, posters, and abstracts involving chimeric virus production and its adaptation.Wrote and edited 12 peer-reviewed original scientific articles and reviews.Served as review editor or peer reviewer of scientific articles for multiple professional journals.Generated molecular vaccine candidates, in-vitro virus production, and characterization. Led the effort for literature search for US Patent application.

Boston, Ma, Us

Designed, implemented, and led the execution of hypothesis-driven research projects.Wrote and edited SOPs, progress reports, abstracts, posters, and PowerPoint presentations, and presented results at local, national, and international scientific meetings.Extensive experience with scientific and clinical research data and statistical analysis using fitting algorithms, graphing, data capture, database software (GraphPad Prism, SigmaPlot), Microsoft Office Suite, and other related software (Adobe Photoshop, Acrobat Pro, and EndNote).

Boston, Ma, Us

Study humoral responses and explore strategies to generate neutralizing monoclonal antibodies from vaccine protected animals.

Developed immunoconjugate with Curcumin for targeted therapy.Contributed to the product development of antibody-based diagnostic products for microbial detection and infectious diseases.Generation of dual-purpose vaccine for contraception and advanced-stage cancers.Established assay for efficacy testing of partner antibodies against prostate cancer in in-vitro and in-vivo models.Studied dose-response in rodents and a conducted wide variety of immuno-oncology and bio-neutralization assays.Designed, implemented, and validated immunoassays to evaluate the cytotoxic effect of curcumin in different cancer cell lines and primary cells.Mentored 5-8 Bachelor’s and Master’s students per year from the Department of Biotechnology.Provided review and editing of content for domestic and international grant proposals. Scientific presentations of grant proposals to renowned groups of scientists and clinicians.

Cancer Immuotherapy

Research on the development of therapeutic antibodies against advanced-stage metastatic cancers (AML/ALL) synthesizing human Chorionic Gonadotropin (hCG).Production of antibodies in plants (as high yield production system), purification and characterization.Generation of companion anti-prostate cancer monoclonals by hybridoma technology. Cell-based assay development, stable and transient transfection studies, immunogenicity and bio-neutralization studies in rodents, pharmacokinetics, antigenicity response, dose-response, and adjuvant efficacy studies.Supported development of probiotics and herbal microbicides for the control of bacterial vaginosis.Project designing, mentoring, protocol development, project management, troubleshooting, and dissertation designing for Master- and Bachelor-level students.

In

Collaborative Researcher

M.Sc. research work on RAPD DNA profiling of Phoenix dactylifera at Plant Biotechnology Center.

Phd, Life Sciences

M.Sc, Biotechology

B.Sc.( Hons) Ag., Agricultural Sciences

Schooling, Senior Secondary Education Certificate